Educating end-stage renal disease patients on dialysis modality selection

Abstract

sponsorship: A.C. received lecture fees from Roche and Amgen, and consultancy fees from Fresenius Medical Care. B.B. received research support from Baxter Healthcare, Roche, Astellas, Amgen and Genzyme. T.L. is a consultant for Baxter Healthcare. R.V. received research grants from Amgen, Novartis, Baxter Healthcare, Roche, Fresenius Medical Care and Gambro. L.S., D.F., O.H. and W.v.B. have no conflict of interest declared. (Baxter Healthcare, Roche, Astellas, Amgen, Genzyme, Novartis, Fresenius Medical Care, Gambro)